Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 78c, Beats on Revenue; Offers FY23 Revenue Guidance
Go back to Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 78c, Beats on Revenue; Offers FY23 Revenue Guidance| Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) | Delayed: 31.39 +0.01 (0.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.38 | 52 Week High | $3.00 | |||
| Open | $31.39 | 52 Week Low | $0.51 | |||
| Day High | $31.40 | P/E | N/A | |||
| Day Low | $31.37 | EPS | $-0.25 | |||
| Volume | 570,390 | |||||
